trié(s) par (Pertinence décroissant(e), Titre croissant(e)) 

Article

Head and neck cancers volume reduction: should we reduce our prophylactic node radiation to spare the antitumor immune response?

Y. El Houat ; L. Bouvier ; M. Baty ; X. Palard-Novello ; Yoann Pointreau ; R. De Crevoisier ; J. Castelli |

Dans Cancer/Radiothérapie (vol. 26, no. 6-7, Octobre 2022)

Radiotherapy for locally advanced head and neck cancer classically include large prophylactic node volume. However, the use of these large volumes can be responsible for significant toxicity. Furthermore, the disappointing results of radioimmuno[...]

Plus d'information... En ligne

Article

A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients

N. Khalladi ; C. Dejean ; M. Bosset ; Yoann Pointreau ; R. Kinj ; S. Racadot ; J. Castelli ; F. Huguet ; S. Renard ; S. Guihard ; Y. Tao ; J.M. Rouvier ; A. Johnson ; J. Bourhis ; S. Xu Shan ; J. Thariat |

Dans Cancer/Radiothérapie (vol. 25, no. 8, Décembre 2021)

/Purpose A Benchmark Case (BC) was performed as part of the quality assurance process of the randomized phase 2 GORTEC 2014-14 OMET study, testing the possibility of multisite stereotactic radiation therapy (SBRT) alone in oligometastatic head[...]

Plus d'information... En ligne